Published: 24-09-2024
Review
WASOG 2023 conference highlights
Abstract 211 | PDF Downloads 31Page e2024045
Inhaled budesonide and pulmonary sarcoidosis revisited
Abstract 285 | PDF Downloads 204Page e2024037
Echocardiographic evaluation of left ventricular mechanics in sarcoidosis patients without overt heart disease: a systematic review and meta-analysis
Abstract 254 | PDF Downloads 190Page e2024042
Original Articles: Clinical Research
Scar sarcoidosis: Clinical features and prognostic significance
Abstract 247 | PDF Downloads 171Page e2024046
Central Nervous System Sarcoidosis: A National-Based registry study
Abstract 259 | PDF Downloads 201Page e2024040
Hydroxychloroquine monotherapy in sarcoidosis: Indications, efficacy, and side effects
Abstract 336 | PDF Downloads 249Page e2024039
Are the gains from pulmonary rehabilitation the same in idiopathic pulmonary fibrosis and other interstitial lung diseases?
Abstract 442 | PDF Downloads 412Page e2024038
Interstitial Lung Disease in Primary Sjögren’s Syndrome: Risk factors for occurrence and radiographic progression
Abstract 360 | PDF Downloads 298Page e2024035
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey
Abstract 344 | PDF Downloads 238Page e2024047
Assessment of quality of life in IPF Patients: a multicenter observational study
Abstract 263 | PDF Downloads 186Page e2024043
Original Articles: Laboratory Research
Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway
Abstract 254 | PDF Downloads 192Page e2024034
Letter to Editor
The fissural involvement in pleuroparenchymal fibroelastosis: Something beyond the alveolar elastosis
Abstract 158 | PDF Downloads 126Page e2024041
Case Reports
Case of familial interstitial lung disease attributed to ATP-binding cassette transporter 3 gene mutation in identical twins
Abstract 250 | PDF Downloads 323Page e2024033